Clinical trial
Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC
NCT00319514 · Gachon University Gil Medical Center, Other · Completed
Key facts
| NCT number | NCT00319514 |
|---|---|
| Title | Weekly Versus 3-Weekly Docetaxel Plus Cisplatin for Advanced NSCLC |
| Official title | Randomized Phase II Trial of Two Different Schedules of Docetaxel Plus Cisplatin as First-Line Therapy in Advanced Non-Small Cell Lung Cancer |
| Lead sponsor | Gachon University Gil Medical Center, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Advanced Non-Small Cell Lung Cancer |
| Intervention type | Drug |
| Interventions | Docetaxel |
| Enrollment | 78 |
| Start date | Apr 1, 2004 |
| Completion | Oct 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | Mar 12, 2008 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: